Main Networks

CIRTN-R2FIC is a leading islet research and training network based in Canada. It was established in 2020 by joint contributions from the University of Alberta, University of British Columbia, University of Manitoba, Université de Montréal, Institut de recherches cliniques de Montréal, and the University of Toronto, and is open to laboratories, investigators, and trainees all across the country. The network currently includes 50 laboratories and over 180 associated researchers and staff engaged in the study of the pancreatic islets of Langerhans. CIRTN-R2FIC seeks to build on Canada’s reputation for excellence in islet biology research by facilitating the exchange of information and ideas with in-person and virtual scientific meetings, by enhancing mentorship and trainee career development, and by promoting engagement and collaboration among islet researchers in Canada and worldwide.

The Canadian Nutrition Society/la Société canadienne de nutrition (CNS/SCN) is the leading Canadian society that integrates disciplines and professions interested in nutrition, including nutrition scientists and professionals, healthcare/clinical practitioners, government and policy makers, industry representatives (food developers, processors, manufacturers and distributors), and future leaders/trainees. Our membership represents close to 1000 professionals from across Canada, the US and globally. The CNS was formed by a merger of the Canadian Society for Clinical Nutrition and the Canadian Society for Nutritional Sciences, and became operational on January 1, 2010.

VISION
CNS is the recognized resource of evidence-based nutrition science and information for all sectors across the nutrition continuum.

MISSION
Communicate and deliver nutrition science and education, and advocate for best practices and policies that promote the value of nutrition for the health and well-being of the Canadian population.

STRATEGIC PRIORITIES
CNS has identified strategic priorities in 4 key areas:

• Education
• Professional Development
• Advocacy
• Capacity and Growth

The CMDO Network is a group of research teams working in Quebec on CardioMetabolic health, Diabetes and Obesity (CMDO). It is one of the thematic networks of the Fonds de recherche du Québec – Santé (FRQS). The network’s mission is to develop research on CMDO themes, to transmit knowledge and to promote the health and quality of life of Quebecers. It supports promising projects, from basic and clinical research to the population, which require a wide range of expertise and multicentre scientific and clinical platforms. Through the development of both provincial and international funding programs involving early career investigators, as well as patient-partnership and student training within these initiatives, the CMDO Network promotes the recruitment and success of talented early career investigators and the emergence of a new generation of high-quality scientists. To this end, the Network will support the various CMDO research sectors, mobilize the main players involved, promote the emergence of partnerships and maximize the benefits.

The CMDO Network has the following strategic objectives

• Promote, establish and strengthen, through meetings and scientific exchanges, collaborations among the teams involved in the different research axes;
• To provide its members with access to specialized platforms and common research services;
• Increase Quebec’s ability to recruit and retain top researchers;
• Promote training;
• Help establish international partnerships;
• Promote knowledge transfer.

The support of a strong linkage to existing and future infrastructure and the development of large cohorts of patients on a multicentre basis in Quebec will undoubtedly have a strong synergistic impact on the future health of the Quebec/Canadian population.

Diabetes Action Canada is a pan-Canadian research organization that was launched in 2016.  DAC is funded jointly by the Canadian Institutes of Health Research’s (CIHR)  Strategic Patient-Oriented Research (SPOR) program, non-profit organizations (e.g. Diabetes Canada, JDRF), and private sponsors. Our Network consists of a diverse team of patient partners, researchers, diabetes specialists, primary care practitioners, nurses, pharmacists, data specialists, and health policy experts committed to improving the lives of persons living with diabetes. We focus on bringing patients, their caregivers and researchers together to identify the health concerns of those living with diabetes and to co-create research projects that address these concerns. We partner and collaborate with university research teams across Canada, non-profit organizations, and provincial governments to plan, execute and evaluate these research projects so that we can improve patient outcomes and experiences.

Our Mission is to develop patient- and research-informed innovations in equitable health care delivery designed to prevent diabetes and its complications and to achieve the Quadruple Aim goals (improve: patient experience; population outcomes; health professional experience; health system cost)

Our Vision is to transform the health trajectory for all Canadian men, women, and children with diabetes and who are at risk for complications

Our mission statement: Grounded in person-centredness and equity, we are a translational diabetes research team dedicated to improving the wellness of children and families across generations by making discoveries that impact clinical care and health policy.

The IMPART investigator team is a national virtual research institute headquartered at Dalhousie Medicine New Brunswick in Saint John, NB. Our team is made up of 45 academic and clinical partners across 8 universities and 6 provinces, as well as 25 community and funding agency members, 15 private sector company representatives, and two provincial government departments. IMPART’s mission is to think boldly and utilize our network to improve the outcomes of vulnerable patient populations, starting always with innovation developed and tested in New Brunswick. We apply intersectional thinking between social and medical innovation and have brought together a diverse and inclusive team of experts to support activities from fundamental research to applied interventions with vulnerable populations.

Our team is aligned with three core principles represented in our name and our practices:

IM = Inflammation & Metabolism: These are the threads that allow cancer to hide and escape from the immune system or defend against chemotherapy, promote weight gain and fibrotic remodelling to cause disease and leave us susceptible to physical and mental stress.

PA = Physical Ability: This is our capacity for exercise and movement, the physical and medical constraints of our bodies that determine how much or how little exercise we enjoy or can tolerate. It is essential to keeping frailty at bay and in the prevention and rehabilitation of patients. The threads that limit us here, can cause disease or limit our ability to recover.

RT = Research Translation: This is how we move our science into clinical practice, by advocating for change, assisting in the commercialization of new technologies and promoting best practices to care for our patients, especially the most vulnerable in our communities.

Obesity Canada is Canada’s leading obesity registered charity, made up of healthcare professionals, researchers, policy makers and people with an interest in obesity.

The mission of Obesity Canada is to improve the lives of Canadians through obesity research,education, and advocacy. The organization’s strategic goals are:
1. Addressing the social stigma associated with obesity;
2. Changing the way policy makers and health professionals approach obesity; and
3. Improving access to evidence-based prevention and treatment resources.

We believe that everyone deserves to be treated with respect and dignity. To this end, ObesityCanada works toward reducing weight bias and stigma through research, education and action. In alignment with its mission and strategic goals, Obesity Canada aims to facilitate knowledge exchange regarding obesity prevention, treatment, and policy.